Brahmer JR, Rodríguez-Abreu D, Robinson AG, et al. Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%. 18th World Conference on Lung Cancer (WCLC) 2017, abstract OA 17.06.
Encorafenib en binimetinib bij niet-resectabel of gemetastaseerd BRAF-gemuteerd melanoom
apr 2019 | Dermato-oncologie